Pharmacy Review Evidence in Workers Compensation Tribunals

Understanding admissibility, expert standards, and effective use of pharmacy reviews in Personal Injury Commission and tribunal proceedings

Published: 4 April 2026

Introduction: The Tribunal Context

Workers compensation disputes that cannot be resolved between insurer and claimant often escalate to tribunal proceedings. In New South Wales, the Personal Injury Commission hears workers compensation disputes. Other states have equivalent bodies: the Workers Compensation Commission (Victoria, Queensland, South Australia) or comparable tribunals. These bodies make binding decisions on disputed claims, treatment entitlements, and liability questions.

Medication appropriateness frequently becomes central to tribunal disputes. Is the prescribed medication reasonably necessary under the Workers Compensation Act? Does the treatment represent evidence-based practice? Should the insurer continue funding this medication? Tribunal members, often not medical practitioners, need expert evidence to resolve these questions.

A pharmacy review from an independent, qualified pharmacist provides that expert evidence. Understanding how tribunals receive this evidence, what standards they apply, and how to present pharmacy review evidence effectively is essential to success in tribunal proceedings.

What Makes Pharmacy Review Evidence Admissible in Tribunal Proceedings

Expert Qualification Standards

For pharmacy review evidence to be admissible in tribunal proceedings, the pharmacist reviewer must meet expert witness standards. This means the reviewer must possess specialist knowledge based on training, study, or experience that goes beyond general knowledge. A pharmacy degree alone is insufficient; the reviewer should have demonstrated experience in medication review, clinical pharmacy practice, and ideally experience in providing expert evidence.

Your legal team should verify the reviewer's qualifications before the tribunal hearing. Questions to consider: Is the reviewer registered as a pharmacist? Do they hold specialist qualifications (clinical pharmacy credentials, Accredited Practitioner status through the Australian Pharmacy Council)? Have they provided expert evidence in tribunal proceedings previously? What is their experience in medication review and workers compensation claims?

Independence From the Insurer

The reviewer must demonstrate independence from the insurer, the treating team, and the dispute parties. Tribunals scrutinise expert evidence for bias. If the reviewer appears to be an insurer advocate rather than an objective expert, the tribunal may discount the evidence.

Independence is demonstrated by clear conflict-of-interest declarations, transparent methodology, and willingness to acknowledge limitations or alternative explanations. If the reviewer identifies medication that should be continued despite the insurer's initial position, that willingness strengthens credibility. The reviewer should be instructed to provide objective expert opinion, not to support the insurer's position.

Methodological Rigor and Transparency

The pharmacy review must be based on transparent, defensible methodology. The report should explain what information was reviewed (medication records, clinical notes, dosing history), what standards were applied (clinical guidelines, TGA guidance, evidence-based practice), and how conclusions were reached. This transparency allows the tribunal to evaluate the reliability of the evidence.

Methodology questions the tribunal may consider: Did the reviewer have access to sufficient information? Were appropriate guidelines applied? Were alternative explanations considered? Is the conclusion supported by the evidence presented? A well-documented methodology withstands tribunal scrutiny; a vague or unsupported methodology will be challenged.

Relevance to the Dispute Question

The pharmacy review must directly address the question the tribunal is considering. If the tribunal is deciding whether medication is "reasonably necessary" under Section 60, the review should explicitly assess reasonableness and necessity. If the dispute concerns treatment refusal, the review should justify that refusal on clinical grounds. If the question is medication safety, the review should address safety evidence.

Unfocused pharmacy reviews that comment broadly on medication appropriateness but do not address the specific tribunal question carry less weight. Your legal team should work with the reviewer to ensure the review scope and conclusions directly address the tribunal's question.

Pharmacy Reviews vs. Treating Pharmacist Opinions

The Difference

There is a crucial distinction between a pharmacy review from an independent expert and an opinion from the claimant's treating pharmacist or the prescribing doctor's pharmacist colleagues. An independent pharmacy review is expert evidence; treating pharmacist opinions are typically treated as part of the treating team's position.

In tribunal proceedings, an independent pharmacy review carries greater evidential weight because it is genuinely independent and can contradict the treating team's position. A treating pharmacist opinion, by contrast, is expected to align with the treating team's position and is scrutinised for independence.

Building Your Case

When you anticipate a tribunal dispute, commission an independent pharmacy review early. Do not rely on feedback from the treating pharmacist or your own internal clinical team; obtain genuinely independent expert evidence. This evidence will be more persuasive to the tribunal because it comes from outside the dispute parties.

How Pharmacy Reviews Support Section 60 Disputes

Section 60 of the Workers Compensation Act 1987 (NSW) and equivalent provisions in other states require the insurer to fund treatment that is "reasonably necessary" to promote recovery. This concept is inherently fact-dependent; what is reasonably necessary varies by injury, recovery stage, and individual circumstance.

A pharmacy review directly informs this question. The reviewer examines whether the medication:

• Addresses an identified clinical need related to the workplace injury
• Is prescribed in accordance with evidence-based guidelines for that condition
• Is provided at a dose and frequency justified by the claimant's clinical status
• Supports recovery and return to work, or merely manages symptoms indefinitely
• Creates safety risks that outweigh clinical benefits

This analysis answers the "reasonably necessary" question with clinical objectivity. The tribunal can rely on the reviewer's assessment to determine what medications are genuinely necessary for the injury and recovery.

Consider this tribunal scenario: a claimant injured two years ago remains on benzodiazepines prescribed for acute anxiety. The insurer argues the medication is no longer necessary; the claimant's treating doctor argues it remains necessary for ongoing anxiety management. A pharmacy review examines the clinical evidence for long-term benzodiazepine use, identifies risks of dependence and cognitive impairment, and assesses whether the medication still addresses the original injury-related anxiety or has become a dependency issue. This evidence shapes the tribunal's assessment of reasonableness and necessity.

Pharmacy Reviews in Treatment Refusal Disputes

When you refuse to fund a treatment or medication, the claimant may challenge that refusal at tribunal. A pharmacy review supports the refusal by providing independent clinical justification.

For example, if you refuse to fund a non-PBS medication available on the PBS at lower cost, a pharmacy review can justify that refusal by analysing whether the non-PBS version offers clinical advantage over the PBS equivalent. If you refuse to fund ongoing opioid therapy, a pharmacy review can provide clinical grounds for that refusal based on guideline non-compliance, dependence risk, or lack of functional improvement.

Treatment refusal disputes are common in tribunal proceedings. Your legal team needs strong clinical evidence to defend the refusal. A pharmacy review provides that evidence in a format tribunals understand and respect: objective expert assessment of clinical appropriateness.

Tribunal Types and Pharmacy Review Use Across Australian States

Preparing Pharmacy Review Evidence for Tribunal Submission

Written Submission Format

The pharmacy review should be prepared as a formal expert report suitable for tribunal submission. Key elements include:

• Reviewer's qualifications and expertise (credentials, experience in medication review and expert evidence)
• Declaration of independence (no financial interest in outcome, no bias toward insurer or claimant)
• Scope of review (which medications, what time period, what clinical questions)
• Methodology (what information reviewed, what standards applied)
• Findings (systematic analysis of each medication or issue)
• Conclusions (clear answers to the clinical questions posed)
• Recommendations (proposed medication changes, deprescribing, or continuation with rationale)

The report should be written for tribunal members who may not have pharmacy expertise. Technical jargon should be minimised or explained. References to guidelines and evidence should be clear enough for a lay tribunal member to understand the basis for conclusions.

Expert Witness Preparation

If your legal team decides to call the pharmacy reviewer as an expert witness for oral testimony, preparation is essential. The reviewer should be prepared for cross-examination by the claimant's legal representatives, who may challenge qualification, methodology, independence, or conclusions.

Before the hearing, your legal team should discuss potential challenges and prepare the reviewer to respond clearly and professionally. The reviewer should be willing to acknowledge limitations of the review, alternative interpretations of evidence, or situations where treatment continuation might be justified. This willingness to acknowledge nuance strengthens credibility.

Case Scenarios: How Pharmacy Review Evidence Shapes Tribunal Outcomes

Scenario 1: Opioid Deprescribing Dispute

A claimant injured in a workplace accident was prescribed opioids in the acute phase. Four years later, the claimant remains on high-dose opioid therapy. The insurer argues the opioids are no longer reasonably necessary and refuses continued funding. The claimant challenges the refusal at tribunal, arguing ongoing pain justifies continued opioids.

A pharmacy review examines opioid therapy against current guidelines, examines functional status, reviews previous deprescribing attempts, and assesses whether the dose exceeds guidelines for the claimant's level of functional improvement. The review finds the opioid dose is 2.5 times higher than guidelines recommend for chronic pain and that the claimant's functional status does not support ongoing high-dose therapy. The review recommends structured deprescribing.

The tribunal receives the pharmacy review alongside the claimant's general practitioner statement supporting continued opioids. The tribunal weights the independent pharmacy evidence, which provides systematic analysis of guidelines and functionality, against the treating doctor's assertion. The independent evidence often prevails because it is more specific and defensible.

Scenario 2: Non-PBS Prescribing Challenge

A claimant is prescribed a medication privately (non-PBS) at significantly higher cost than the PBS equivalent. The insurer challenges funding of the private prescription and argues the PBS equivalent should be used.

A pharmacy review compares the non-PBS and PBS versions, examining whether the non-PBS version offers clinical advantage that justifies the higher cost. The review finds the PBS and non-PBS versions are bioequivalent and that there is no clinical justification for private prescribing. The pharmacy review supports the insurer's position that the PBS version should be used, reducing costs while maintaining clinical appropriateness.

The tribunal hears the pharmacy review evidence, the treating doctor's preference for the private formulation (if stated), and cost implications. The independent clinical analysis typically supports cost-effective PBS prescribing unless the treating doctor presents specific clinical justification for the private version.

Scenario 3: Medication Error and Adverse Outcome

A claimant suffered an adverse outcome (hospitalisation, serious adverse effect) allegedly caused by a medication dispensing error. The claimant alleges the pharmacy dispensed the wrong dose or failed to flag a dangerous drug interaction. The claimant seeks compensation for the adverse outcome.

A pharmacy review examines the medication records, identifies the error, assesses whether the error was foreseeable and should have been prevented by pharmacy checks, and determines causation between the error and the adverse outcome. The review provides technical expertise on pharmacy standards and error prevention practices that the tribunal members lack.

The tribunal uses the pharmacy review evidence to determine whether an error occurred, whether it was negligent, and whether it caused the adverse outcome. This expert evidence is essential because tribunal members cannot independently assess pharmacy practice standards.

Strengthening Your Position: What Tribunals Look For

Clear, Defensible Conclusions

Tribunals favour pharmacy reviews with clear, specific conclusions that directly address the dispute question. Avoid vague findings ("medication may not be appropriate" rather than "medication is not consistent with current guidelines for this condition"). Specific conclusions are harder to challenge and more persuasive.

Acknowledgment of Complexity and Uncertainty

Pharmacy reviews that acknowledge complexity and reasonable disagreement are more credible. If there are legitimate alternative explanations for medication choice or reasonable arguments for continued use, the reviewer should acknowledge these while explaining why the evidence favours the reviewer's conclusion. This nuance demonstrates expertise and fairness.

Grounding in Evidence and Guidelines

Every conclusion should be traceable to specific evidence (guidelines, clinical literature, TGA guidance, professional standards). When the reviewer states a medication is "not recommended," cite the guideline that does not recommend it. This makes the review defensible against challenge.

Proportionality and Balance

Pharmacy reviews that fairly acknowledge the treating doctor's position while presenting independent analysis are more persuasive. Avoid reviews that appear one-sided or dismissive of treating practitioners. Tribunals expect expert evidence to be balanced and professional, even when disagreeing with treatment decisions.

Common Tribunal Questions and How Pharmacy Reviews Answer Them

• Is this medication reasonably necessary under Section 60? Pharmacy review examines clinical appropriateness, guideline compliance, and functional justification.
• Does this medication support recovery and return to work? Pharmacy review assesses whether the medication contributes to functional improvement or merely manages symptoms indefinitely.
• Is this high-risk prescribing appropriate? Pharmacy review compares the prescription against guidelines for high-risk medications (opioids, benzodiazepines) and assesses safety risks.
• Should this medication continue or be ceased? Pharmacy review provides clinical grounds for continuation or cessation based on evidence and guidelines.
• Is this private prescribing justified? Pharmacy review compares non-PBS and PBS versions and justifies cost differences on clinical grounds.
• Did a medication error occur? Pharmacy review identifies dispensing or prescribing errors and assesses whether they were preventable.

Working With Your Legal Team on Pharmacy Review Evidence

Your legal team should be involved in referring for the pharmacy review. Key discussion points include:

• What specific clinical question does the tribunal need answered?
• What scope of review is most relevant to that question?
• What expert witness qualifications are essential for the reviewer?
• What timeline is needed to obtain the review before tribunal proceedings?
• How will the review be presented (written evidence only or with expert witness testimony)?
• What potential challenges might the claimant's legal team raise, and how will the reviewer respond?

Your legal team's involvement ensures the pharmacy review is tailored to tribunal proceedings and meets evidentiary standards.

Key Takeaways

Pharmacy review evidence carries significant persuasive weight in tribunal proceedings because it provides independent expert assessment grounded in clinical principles and evidence-based practice. When you anticipate a tribunal dispute involving medication appropriateness, an independent pharmacy review should be commissioned early as central evidence supporting your position.

Ensure the reviewer meets expert witness standards, operates independently from the insurer, applies transparent and defensible methodology, and directly addresses the tribunal's core question. A well-prepared pharmacy review often determines the outcome of tribunal disputes on medication necessity, cost-effectiveness, and clinical appropriateness.